Drug Shortage Report for TEVA-LANSOPRAZOLE
| Report ID | 195879 |
| Drug Identification Number | 02280523 |
| Brand name | TEVA-LANSOPRAZOLE |
| Common or Proper name | TEVA-LANSOPRAZOLE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | LANSOPRAZOLE |
| Strength(s) | 30MG |
| Dosage form(s) | CAPSULE (DELAYED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-06-19 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-03-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v24 | 2024-03-18 | French | Compare |
| v23 | 2024-03-18 | English | Compare |
| v22 | 2024-02-01 | French | Compare |
| v21 | 2024-02-01 | English | Compare |
| v20 | 2024-01-18 | French | Compare |
| v19 | 2024-01-18 | English | Compare |
| v18 | 2023-11-03 | French | Compare |
| v17 | 2023-11-03 | English | Compare |
| v16 | 2023-10-12 | French | Compare |
| v15 | 2023-10-12 | English | Compare |
| v14 | 2023-10-03 | French | Compare |
| v13 | 2023-10-03 | English | Compare |
| v12 | 2023-08-04 | French | Compare |
| v11 | 2023-08-04 | English | Compare |
| v10 | 2023-07-20 | French | Compare |
| v9 | 2023-07-20 | English | Compare |
| v8 | 2023-07-11 | French | Compare |
| v7 | 2023-07-11 | English | Compare |
| v6 | 2023-07-04 | French | Compare |
| v5 | 2023-07-04 | English | Compare |